Sponsored by:

Drug Discovery Impact mABs

Rapid analytical solutions for environmental monitoring, in-process and lot releasing testing

The way forward in biotherapeutic analytics:

Rapid analytical solutions for environmental monitoring, in-process and lot releasing testing

Applied Biosystems “SEQ” rapid analytical solutions for pharmaceutical manufacturing help assess the quality and safety of your pharmaceutical products when accuracy and time-to-results are critical. These methods detect impurities and identify contaminants by using molecular techniques such as DNA sequencing, PCR, and are rapidly becoming the standard for pharmaceutical analytics worldwide.

This eBook explores the impact of monoclonal antibodies (mAbs) on the treatment of cancer, autoimmune and infectious diseases, and inflammatory conditions, as well as the latest clinical research and where the innovation in mAb development might be in the future.

Download this exclusive eBook to learn more about:

  • The range of applications for mAbs
  • The latest advances in protein and antibody engineering
  • Clinical innovation in mAb development
  • The future potential for therapeutic antibodies

Download Now